- Home
- ATCH vs PALI Comparison
ATCH vs PALI Comparison
Compare ATCH & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATCH
- PALI
- Stock Information
- Founded
- ATCH 2022
- PALI 1996
- Country
- ATCH United States
- PALI United States
- Employees
- ATCH N/A
- PALI N/A
- Industry
- ATCH
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ATCH
- PALI Health Care
- Exchange
- ATCH Nasdaq
- PALI Nasdaq
- Market Cap
- ATCH 3.2M
- PALI 3.2M
- IPO Year
- ATCH N/A
- PALI N/A
- Fundamental
- Price
- ATCH $0.21
- PALI $0.70
- Analyst Decision
- ATCH
- PALI Strong Buy
- Analyst Count
- ATCH 0
- PALI 2
- Target Price
- ATCH N/A
- PALI $12.00
- AVG Volume (30 Days)
- ATCH 7.7M
- PALI 410.9K
- Earning Date
- ATCH 05-16-2025
- PALI 05-12-2025
- Dividend Yield
- ATCH N/A
- PALI N/A
- EPS Growth
- ATCH N/A
- PALI N/A
- EPS
- ATCH 2.67
- PALI N/A
- Revenue
- ATCH N/A
- PALI N/A
- Revenue This Year
- ATCH N/A
- PALI N/A
- Revenue Next Year
- ATCH N/A
- PALI N/A
- P/E Ratio
- ATCH $0.08
- PALI N/A
- Revenue Growth
- ATCH N/A
- PALI N/A
- 52 Week Low
- ATCH $0.18
- PALI $0.60
- 52 Week High
- ATCH $83.99
- PALI $5.15
- Technical
- Relative Strength Index (RSI)
- ATCH 33.79
- PALI 44.12
- Support Level
- ATCH $0.19
- PALI $0.67
- Resistance Level
- ATCH $0.23
- PALI $0.86
- Average True Range (ATR)
- ATCH 0.02
- PALI 0.06
- MACD
- ATCH 0.02
- PALI -0.01
- Stochastic Oscillator
- ATCH 38.18
- PALI 22.24
About ATCH AtlasClear Holdings Inc. Common Stock
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.